🔴 LIVE — Tracking all US product recalls in real-time from FDA, CPSC, NHTSA & USDA
Ad Space — 728×90

Meclizine Tablets Recalled Due to Failed Specs

🟡 MODERATE RISK — CLASS II
Agency: Food and Drug Administration (FDA)  |  Date: 20260401  |  Units: 697 cartons  |  Risk: Class II

This alert was compiled from official government recall data published by the FDA using automated analysis. All facts are sourced directly from official records. Last verified April 8, 2026.

Meclizine Hydrochloride Tablets, USP 12.5 mg, (a) 50 Tablets [5 x 10] (NDC 60687-775-65) (b) 12.5 mg Individual Dose ( NDC 60687-775-11), Rx Only, Distributed by: American Health Packaging, Columbus, Ohio, 43217. recalled by Amerisource Health Services LLC - Failed tablet specifications.

Stock photo for illustration — not the actual recalled product. Photo by Karim Ghantous on Unsplash

So here's something you need to know about if you take Meclizine Hydrochloride tablets: Amerisource Health Services LLC, the company that distributes American Health Packaging's Meclizine Hydrochloride Tablets, USP 12.5 mg, has issued a product recall in the United States. If you're one of the many American shoppers who purchase medications like this, it's worth paying attention.

Why the Meclizine Hydrochloride Tablets Were Recalled

Nobody wants to find out their medication isn't up to snuff. Amerisource Health Services LLC is recalling specific lots of American Health Packaging Meclizine Hydrochloride Tablets, USP 12.5 mg, because the tablets don't meet the required specifications. In simpler terms, there's something wrong with the tablets themselves. The agency confirmed that this constitutes a Class II recall, meaning use of the recalled product could cause temporary or medically reversible adverse health consequences. The recall impacts both the 50-tablet bottles and the individual dose packaging.

The full details, based on the official recall notice, state that the tablets failed to meet established standards. While the FDA announcement doesn't specify the precise nature of the failure, it's important to take this recall seriously and assess if you're affected. If you have questions for an expert, tell your doctor or pharmacist you're concerned about failed tablet specifications, and give them the product packaging information to review.

Which Products Are Affected?

This recall affects a specific lot of Meclizine Hydrochloride Tablets, USP 12.5 mg, distributed by American Health Packaging:

  • Product: Meclizine Hydrochloride Tablets, USP 12.5 mg, Rx Only
    • (a) 50 Tablets [5 x 10]
    • (b) 12.5 mg Individual Dose
  • NDC:
    • (a) 60687-775-65
    • (b) 60687-775-11
  • Distributed by: American Health Packaging, Columbus, Ohio, 43217
  • Lot Number: 1024852
  • Expiration Date: 9/30/2026
  • Units Affected: 697 cartons
  • Distribution: U.S. Nationwide

These medications were sold across the U.S. through various pharmacies and healthcare providers. This medication might be in your medicine cabinet, no matter what U.S. state you live in.

Severity of the Recall

The FDA has classified this as a Class II recall. This means that the use of or exposure to the recalled product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote. While the risk may not be high, it is still important to take action if you have the affected product.

What You Should Do Right Now

If you think you have this product, here's what to do:

  1. Stop using the affected Meclizine Hydrochloride Tablets, USP 12.5 mg, immediately if the lot number on your package is 1024852.
  2. Check your medicine cabinet and any other places where you store medications to see if you have the affected lot.
  3. Contact your healthcare provider or pharmacist to discuss alternative medications or address any concerns you might have.
  4. Return the affected product to the pharmacy where you purchased it for proper disposal.

Background on Recalling Company

Amerisource Health Services LLC distributes products from American Health Packaging. It is worth noting that while every recall is serious, it’s not uncommon for pharmaceutical companies to issue recalls to ensure product quality. Maintaining patient safety is the top priority.

This recall was announced by the U.S. Food and Drug Administration (FDA). For the official notice and complete details, visit www.fda.gov.

Frequently Asked Questions

Q: What does "failed tablet specifications" actually mean?

It means the tablets don't meet the required standards for things like potency, purity, or how they dissolve. This could affect how the medication works.

Q: Is this a nationwide recall?

Yes, the Meclizine Hydrochloride Tablets were distributed throughout the United States, so the recall affects people across the country. You may have purchased this medication from your local pharmacy, regardless of what state you live in.

Q: What are the symptoms of taking a defective Meclizine Hydrochloride tablet?

Because the recall is due to failed specifications, symptoms are not listed. Contact your doctor if you're concerned about symptoms related to this medication.

Q: How do I find the lot number on my medication?

The lot number (1024852 in this case) is usually printed on the side of the bottle or box, or on the blister pack if it's individually packaged. Look for "Lot" or "LOT" followed by a series of numbers.

Q: Will I get a refund for the recalled medication?

You should contact the pharmacy where you purchased the medication to inquire about their return and refund policy for recalled products. They will likely be able to assist you with a refund or replacement.

⚠️ If You Own This Product:
Stop using it right away and follow the steps above. You may be entitled to a full refund, free repair, or replacement at no cost.
This article is based on official recall data from the Food and Drug Administration (FDA). Last verified on April 8, 2026.
Ad Space — In Article